APLIF News and Press, Appili Therapeutics Inc From 09/09/25

HALIFAX, Nova Scotia, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced that Carl Gelhaus,...

2025-08-15 09:24:05 ET More on Appili Therapeutics Inc. Financial information for Appili Therapeutics Inc. Read the full article on Seeking Alpha For further details see: Appili Therapeutics GAAP EPS of -$0.01

Submitted two additional U.S. government funding proposals during the quarter, bringing the total proposals to US$137 million Accepted as a new member of U.S. Medical CBRN Defense Consortium, strengthening government and biodefense partnerships HALIFAX, Nova Scotia, Aug. 14, 202...

Reeds Inc. (REED) is expected to report $-0.04 for Q2 2025 Jerash Holdings (US) Inc. (JRSH) is expected to report for Q1 2026 Churchill Capital Corp IX (CCIX) is expected to report for quarter end 2025-06-30 Verde Clean Fuels Inc. (VGAS) is expected to report for Q2 2025 Mobile In...

Peer-reviewed publication highlights ATI-1701’s robust protection against aerosolized Francisella tularensis exposure in multiple animal models HALIFAX, Nova Scotia, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or ...

2025-07-24 09:35:00 ET Aditxt (NASDAQ: ADTX) , a social innovation platform advancing health technologies, announced that its subsidiary Pearsanta, Inc. has been invited to submit a full proposal for the U.S. Department of Defense’s OCRP Pilot Award. The proposal supports Pearsan...

2025-07-22 09:35:00 ET Aditxt (NASDAQ: ADTX) , a social innovation platform advancing health solutions, will host a livestream on July 22, 2025, at 1:00 p.m. ET to highlight its autoimmune therapeutics subsidiary, Adimune Inc. The event, hosted by Jack Marks of Wall Street Reporter, wil...

LIKMEZ™ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL re-launched and commercial sales ongoing Five U.S. government proposals submitted, totalling up to US$125 million HALIFAX, Nova Scotia, June 25, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX:APLI; OTC...

Foresight Autonomous Holdings Ltd. (FRSX) is expected to report for quarter end 2025-03-31 Volatus Aerospace (VLTTF) is expected to report for quarter end 2025-03-31 SJM Holdings Limited (SJMHF) is expected to report for quarter end 2025-03-31 FedEx Corporation (FDX) is expected to re...

Appili Therapeutics Inc (APLIF) is expected to report for quarter end 2025-03-31